1-310-598-5410
investor.relations@opiant.com
Home
About Us
Corporate Overview
Management Team
Board of Directors
Medical Advisory Board
Media
Careers
Science and Technology
Burden of Substance Use and Eating Disorders
The Science of Addiction
Opioid Antagonists
Nasal Spray Delivery Technology
Publications
Intellectual Property
Products and Pipeline
Pipeline Chart
Opioid Overdose Reversal
Alcohol Use Disorder
Eating Disorders
Heroin Vaccine
Investor Relations
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
News Releases
Events & Presentations
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Financials & Filings
SEC Filings
Annual Reports & Proxy Statements
Investor Resources
Information Request
IR Contact
Email Alerts
Home
About Us
Corporate Overview
Management Team
Board of Directors
Medical Advisory Board
Media
Careers
Science and Technology
Burden of Substance Use and Eating Disorders
The Science of Addiction
Opioid Antagonists
Nasal Spray Delivery Technology
Publications
Intellectual Property
Products and Pipeline
Pipeline Chart
Opioid Overdose Reversal
Alcohol Use Disorder
Eating Disorders
Heroin Vaccine
Investor Relations
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
News Releases
Events & Presentations
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Financials & Filings
SEC Filings
Annual Reports & Proxy Statements
Investor Resources
Information Request
IR Contact
Email Alerts
Board of Directors
More Info
Roger Crystal, MD
Chief Executive Officer
More Info
Gabrielle A. Silver, MD
Lead Independent Director
More Info
Michael Sinclair, MD
Director
More Info
Richard J. Daly
Independent Director
More Info
Ann MacDougall, JD
Independent Director
More Info
Thomas T. Thomas
Independent Director
